United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53746-541_b0e32570-da9f-4fa8-a0a2-0334fce7ff7a
- Product NDC
- 53746-541
- Form
- TABLET, FILM COATED
- Composition / generic term
- CYCLOBENZAPRINE HYDROCHLORIDE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100218
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (53746-541-01) · 53746-541-01
- 500 TABLET, FILM COATED in 1 BOTTLE (53746-541-05) · 53746-541-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (53746-541-10) · 53746-541-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →